Medicago to present at WHO meeting
February 17, 2010 by leonardzehr · Leave a Comment
Medicago (TSX:MDG) will present its Phase 1 clinical findings of the first plant-made influenza vaccine to be tested in humans at a meeting this week of the World Health Organization, evaluating pandemic influenza prototype vaccines in clinical trials. “It is a privilege to be among a select group of leading vaccine companies invited to present [...]
Listen to BioTuesdays 
